Results 311 to 318 of about 395,211 (318)

Tissue Distribution of the Death Ligand TRAIL and Its Receptors

Journal of Histochemistry and Cytochemistry, 2004
Elisabeth G De Vries, Edo Vellenga, Jan J Koornstra   +2 more
exaly  

Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications

Drug Resistance Updates, 2004
Sharmila Shankar, Rakesh K Srivastava
exaly  

Happy Trails

IEEE Multimedia, 2006
openaire   +1 more source

Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan

Cell Death and Differentiation, 2000
U Ramp, Henning Walczak, Ramp U
exaly  

TRAIL and cancer therapy

Cancer Letters, 2008
Frank A E Kruyt
exaly  

Follow the trail: Using insights from the growth of palliative care to propose a roadmap for cancer rehabilitation

Ca-A Cancer Journal for Clinicians, 2019
Kathleen Doyle Lyons, Lynne S Padgett, Timothy F Marshall   +2 more
exaly  

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs

Cell Death and Differentiation, 2004
Martin R Sprick, Andreas Krueger, Stremmel W   +2 more
exaly  

TRAIL as a target in anti-cancer therapy

Cancer Letters, 2009
exaly